Hogan Lovells International LLP team in Brussels is well placed to advise on EU, Belgian, French, and Portuguese law. The practice offers comprehensive support to pharmaceutical, medical device, and healthcare clients across regulatory, IP, product liability, and data protection matters. Cláudia Mendes Pinto advises on a wide range of regulatory and commercial issues. Practice head Fabien Roy left the firm in January 2026.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Dedicated associates who are both practical and professional. Very collaborative and helpful to our organisation.’
- ‘Hélène Boland has been standout to work with. She listens to what information we have and is focused on what we need as a result, or is able to provide us with guidance to obtain a better result than we had envisioned on our own.’
Key clients
- Adverum Biotechnologies
- Celgene Corporation
- AESGP
Work highlights
Advised Adverum, a clinical-stage gene therapy company focused on addressing unmet medical needs in ocular and rare diseases, on establishing a framework compliant with the Clinical Trials Regulation and the GDPR for their clinical trials and future activities worldwide.
Advises Celgene on an ongoing basis with supply chain, manufacturing and clinical trials regulatory aspects throughout Europe concerning its authorised and investigational Advanced Therapy Medicinal Products (ATMPs).
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Other key lawyers
Cláudia Mendes Pinto; Hélène Boland; Anastasia Vernikou